Genzyme

XENPOZYME

Manufacturer:

Genzyme

Xenpozyme HCPCS:

J0218

HCPCS Code Descriptor:

Injection, olipudase alfa-rpcp, 1 mg

Category:

J Code

Xenpozyme NDCs:

58468-0051-01, 58468-0050-01

Primary Type:

Enzyme Replacement Therapy

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Xenpozyme CPT Codes:

Potential CPT administration codes for Xenpozyme can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Xenpozyme:

XENPOZYME is an Enzyme Replacement Therapy drug manufactured by Genzyme and administered via the Intravenous route of administration. The J Code: J0218 is aligned to the drug XENPOZYME.

ACCESS PRICING AND MORE BY REGISTERING

J0218 Added Date:

April 1, 2023

J0218 Effective Date:

April 1, 2023

J0218 Termination Date:

HCPCS Active

Xenpozyme billing and coding information can be found through Genzyme at the link below:
Xenpozyme patient assistance information can be found through CareConnectPSS at the URL: https://www.xenpozyme.com/resources-and-support/financial-assistance
XENPOZYME prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for XENPOZYME. Please check back in a few weeks.